On September 28, 2022, Mark C. Wiggins notified TRACON Pharmaceuticals, Inc. that he was resigning as the Company's Chief Business Officer, effective September 30, 2022, to pursue other professional opportunities. Mr. Wiggins' resignation is not a result of any disagreement with the Company, and he has agreed to serve as a consultant to the Company following his resignation.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.51 USD | -1.31% | -24.09% | -58.17% |
May. 14 | Transcript : TRACON Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Earnings Flash (TCON) TRACON PHARMACEUTICALS Posts Q1 Revenue $100,000 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-58.17% | 3.48M | |
-2.32% | 92.59B | |
+3.68% | 41.43B | |
-10.93% | 33.49B | |
-20.19% | 14.62B | |
-9.11% | 12.77B | |
-11.34% | 11.58B | |
-43.53% | 11.35B | |
+3.75% | 8.97B | |
-6.32% | 8.3B |
- Stock Market
- Equities
- TCON Stock
- News TRACON Pharmaceuticals, Inc.
- Tracon Pharmaceuticals, Inc. Resigns Mark C. Wiggins as Chief Business Officer